951 related articles for article (PubMed ID: 32942913)
21. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
22. Predictors of Early (1-Week) Outcomes Following Left Atrial Appendage Closure With Amplatzer Devices.
Koskinas KC; Shakir S; Fankhauser M; Nietlispach F; Attinger-Toller A; Moschovitis A; Wenaweser P; Pilgrim T; Stortecky S; Praz F; Räber L; Windecker S; Meier B; Gloekler S
JACC Cardiovasc Interv; 2016 Jul; 9(13):1374-83. PubMed ID: 27388826
[TBL] [Abstract][Full Text] [Related]
23. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
Ramlawi B; Abu Saleh WK; Edgerton J
Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
[TBL] [Abstract][Full Text] [Related]
24. Left atrial appendage closure: First in man with the 4th generation WATCHMAN device.
Ledwoch J; Franke J; Gonzaga M; Bertog S; Braut A; Hofmann I; Vaskelyte L; Gafoor S; Reddy V; Sievert H
Catheter Cardiovasc Interv; 2016 Mar; 87(4):787-94. PubMed ID: 26354821
[TBL] [Abstract][Full Text] [Related]
25. The value of the left atrial appendage orifice perimeter of 3D model based on 3D TEE data in the choice of device size of LAmbre™ occluder.
Jia D; Zhou Q; Song HN; Zhang L; Chen JL; Liu Y; Kong B; He FZ; Wang YJ; Yang YT
Int J Cardiovasc Imaging; 2019 Oct; 35(10):1841-1851. PubMed ID: 31134413
[TBL] [Abstract][Full Text] [Related]
26. Intracardiac versus transesophageal echocardiography for left atrial appendage occlusion with watchman.
Frangieh AH; Alibegovic J; Templin C; Gaemperli O; Obeid S; Manka R; Holy EW; Maier W; Lüscher TF; Binder RK
Catheter Cardiovasc Interv; 2017 Aug; 90(2):331-338. PubMed ID: 27649848
[TBL] [Abstract][Full Text] [Related]
27. Early Canadian Multicenter Experience With WATCHMAN for Percutaneous Left Atrial Appendage Closure.
Saw J; Fahmy P; Azzalini L; Marquis JF; Hibbert B; Morillo C; Carrizo A; Ibrahim R
J Cardiovasc Electrophysiol; 2017 Apr; 28(4):396-401. PubMed ID: 28128883
[TBL] [Abstract][Full Text] [Related]
28. Procedural success and intra-hospital outcome related to left atrial appendage morphology in patients that receive an interventional left atrial appendage closure.
Fastner C; Behnes M; Sartorius B; Wenke A; El-Battrawy I; Ansari U; Gill IS; Borggrefe M; Akin I
Clin Cardiol; 2017 Aug; 40(8):566-574. PubMed ID: 28409845
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Multimodality LAA Leak Closure Methods Following Incomplete Occlusion: The LAA Leak Study.
Charate R; Ahmed A; Della Rocca DG; Bloom S; Garg J; Pothineni NVK; DiBiase L; Turagam M; Gopinathannair R; Horton R; Kar S; Fontana G; Doshi SK; Swarup V; Finn A; Reddy V; Natale A; Lakkireddy D
JACC Cardiovasc Interv; 2022 Nov; 15(21):2158-2170. PubMed ID: 36357020
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous Left Atrial Appendage Closure With the Watchman Device: Long-Term Results Up to 5 Years.
Wiebe J; Franke J; Lehn K; Hofmann I; Vaskelyte L; Bertog S; Sievert H
JACC Cardiovasc Interv; 2015 Dec; 8(15):1915-1921. PubMed ID: 26738659
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous left atrial appendage closure in the presence of thrombus: A feasibility report.
Bordignon S; Bologna F; Chen S; Konstantinou A; Tsianakas N; Tohoku S; Trolese L; Chun KJ; Schmidt B
J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2858-2863. PubMed ID: 31638713
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous left atrial appendage occlusion in patients with atrial fibrillation and left appendage thrombus: feasibility, safety and clinical efficacy.
Tarantini G; D'Amico G; Latib A; Montorfano M; Mazzone P; Fassini G; Maltagliati A; Ronco F; Saccà S; Cruz-Gonzalez I; Ibrahim R; Freixa X
EuroIntervention; 2018 Jan; 13(13):1595-1602. PubMed ID: 29086706
[TBL] [Abstract][Full Text] [Related]
33. Computed tomography measurement of the left atrial appendage for optimal sizing of the Watchman device.
Xu B; Betancor J; Sato K; Harb S; Abdur Rehman K; Patel K; Kumar A; Cremer PC; Jaber W; Rodriguez LL; Schoenhagen P; Wazni O
J Cardiovasc Comput Tomogr; 2018; 12(1):50-55. PubMed ID: 29223726
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous Left Atrial Appendage Closure Is a Reasonable Option for Patients With Atrial Fibrillation at High Risk for Cerebrovascular Events.
Teiger E; Thambo JB; Defaye P; Hermida JS; Abbey S; Klug D; Juliard JM; Pasquie JL; Rioufol G; Lepillier A; Elbaz M; Horvilleur J; Brenot P; Pierre B; Le Corvoisier P;
Circ Cardiovasc Interv; 2018 Mar; 11(3):e005841. PubMed ID: 29540492
[TBL] [Abstract][Full Text] [Related]
35. Left atrial enlargement and clinical considerations in patients with or without a residual interatrial shunt after closure of the left atrial appendage with the WATCHMAN™-device.
Luani B; Groscheck T; Genz C; Tanev I; Rauwolf T; Herold J; Medunjanin S; Schmeisser A; Braun-Dullaeus RC
BMC Cardiovasc Disord; 2017 Dec; 17(1):294. PubMed ID: 29233088
[TBL] [Abstract][Full Text] [Related]
36. Feasibility of percutaneous left atrial appendage closure using a novel LAmbre occluder in patients with atrial fibrillation: Initial results from a prospective cohort registry study.
Chen S; Schmidt B; Bordignon S; Bologna F; Nagase T; Tsianakas N; Perrotta L; Chun KRJ
J Cardiovasc Electrophysiol; 2018 Feb; 29(2):291-297. PubMed ID: 29149516
[TBL] [Abstract][Full Text] [Related]
37. Left atrial appendage occlusion with the WATCHMAN™ for stroke prevention in atrial fibrillation.
Price MJ
Rev Cardiovasc Med; 2014; 15(2):142-51. PubMed ID: 25051131
[TBL] [Abstract][Full Text] [Related]
38. Early results with the LARIAT device for left atrial appendage exclusion in patients with atrial fibrillation at high risk for stroke and anticoagulation.
Stone D; Byrne T; Pershad A
Catheter Cardiovasc Interv; 2015 Jul; 86(1):121-7. PubMed ID: 23765504
[TBL] [Abstract][Full Text] [Related]
39. Left atrial appendage closure for "primary primary" prevention during percutaneous closure of septal defects in patients with large atria but no atrial fibrillation.
Kuwata S; Vierecke J; Gloekler S; Maisano F; Meier B; Nietlispach F
Cardiol J; 2018; 25(2):179-187. PubMed ID: 28840592
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous management of late leak after lariat transcatheter ligation of the left atrial appendage in patients with atrial fibrillation at high risk for stroke.
Mosley WJ; Smith MR; Price MJ
Catheter Cardiovasc Interv; 2014 Mar; 83(4):664-9. PubMed ID: 24214652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
